Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Readcrest Capital AG | EXJ | Sep 19, 2024 | 1.00 | 0.00 |
Reading International Inc - Class A Non-voting | 46B | Sep 19, 2024 | 1.39 | -5.44 |
Readly International | 5GS1 | Sep 19, 2024 | 1.22 | -0.41 |
Ready Capital Corproation | 0SZ | Sep 19, 2024 | 7.20 | +1.41 |
REAL CONS.IT B.S. EO 0,4 | K2Q | Sep 19, 2024 | 3.39 | +0.59 |
REAL ESTATE SPLIT CORP. | FJ8 | Sep 19, 2024 | 8.55 | -1.16 |
Real Heart | 782 | Sep 19, 2024 | 0.02 | +3.30 |
Real Matters Inc | R3E | Sep 19, 2024 | 5.40 | +0.93 |
REALBOTIX CORP. | 76M0 | Sep 19, 2024 | 0.07 | 0.00 |
RealFiction | 7VL | Sep 19, 2024 | 1.82 | +0.44 |
Realia Business, S.A. | RBS | Sep 19, 2024 | 0.97 | +0.41 |
Realites | 2ZQ | Sep 19, 2024 | 6.00 | -5.96 |
Realogy Holdings Corp. | 04M | Sep 19, 2024 | 4.88 | +2.95 |
Realord Group Holdings Limited | CUV | Sep 19, 2024 | 0.61 | 0.00 |
ReAlpha Tech | Z4U | Sep 19, 2024 | 1.25 | +1.87 |
Realty Income Corp. | RY6 | Sep 19, 2024 | 54.27 | -2.79 |
Reaves Utility Income Fund | 074 | Sep 19, 2024 | 27.90 | -0.69 |
REC Silicon | R3Q | Sep 19, 2024 | 0.72 | +3.54 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | Sep 19, 2024 | 0.28 | -2.08 |
Reckitt Benckiser Group Plc | 3RBB | Sep 19, 2024 | 10.90 | +0.93 |
Reckitt Benckiser Group PLC | 3RB | Sep 19, 2024 | 54.72 | -0.80 |
Reckon Ltd. | UVW | Sep 19, 2024 | 0.30 | +15.38 |
Reconnaissance Energy Africa Ltd | 0XD | Sep 19, 2024 | 0.65 | +3.19 |
Recordati SpA | RER1 | Sep 19, 2024 | 50.30 | 0.00 |
Recreate ASA | 6R4 | Sep 19, 2024 | 0.04 | 0.00 |
Recruit Holdings Co. Ltd. | 1RH | Sep 19, 2024 | 56.76 | +5.62 |
Recruit Holdings Co. Ltd. American Depositary Receipts - Uns | 1RHA | Sep 19, 2024 | 10.60 | +6.00 |
Recticel SA | RCZ | Sep 19, 2024 | 13.18 | +2.01 |
RECYCLICO BATTERY METALS | ID4 | Sep 19, 2024 | 0.07 | 0.00 |
Red 5 Ltd. | RKM | Sep 19, 2024 | 0.20 | -1.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.